0
Upcoming Allied Market Research
2023
Blood And Organ Bank Market

Blood and Organ Bank Market

by Product (Red Blood Cell Collection, Processing, and Distribution Services, Blood Plasma Collection, Processing, and Distribution Services, Organ Bank Services, Tissue Bank Services, Health Screening Services, All Other Human Blood Services, Reproductive and Stem Cell Bank Services), by Activity (Collecting Blood, Storing Blood, Distributing Blood, Storing Organs, Distributing Organs, Researching Storage Technologies, Reproducing Tissues) and by End-User (Hospitals, Diagnostic Centers, Blood Banks, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A03015
Nov 2023 | Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Blood And Organ Bank Market

Request Now !

The blood bank is a place where blood and plasma samples are stored for the transfusion process. Blood transfusion is needed in the case of accidental emergency or blood loss disorders such as thalassemia, sickle cell anemia, blood cancer, and anemia. The organ bank is similar to blood banks that stores body organs for organ transplantation. Organ transplantation is a process of surgically replacing diseased or failed organs with another organ.

Factors such as the rising prevalence of hematological diseases such as thalassemia, sickle cell anemia, blood cancer, and anemia, increasing accidental cases, and rising geriatric population drive the market growth. In addition, increase in the awareness of the population, along with rising biotechnological research and development studies fuel the growth of this market. However, post-operative complications such as allergic reactions, fever, acute hemolytic reaction, blood borne infection, and arthritis are expected to restrain the market growth. Blood transfusion and organ transplantation in emerging nations are anticipated to create new opportunities during the forecast period

The blood and organ bank market is segmented based on product, activity, end-user, and geography. By product, it is categorized into red blood cell collection, processing, distribution services, blood plasma collection, processing, distribution services, organ bank services, tissue bank services, health screening services, all other human blood services, and reproductive & stem cell bank services. By activity the market is segmented into collecting blood, storing blood, distributing blood, storing organs, distributing organs, research & storage technologies, and reproductive tissues. By end-user the market is categorized into hospitals, diagnostics centers, blood bank, and others. Geographically, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

  • The study provides an in-depth analysis of the blood and organ bank market, with current trends and future estimations to elucidate investment pockets.
  • Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
  • The report offers a quantitative analysis to help stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of different segments determines various products available in the market.
  • Key players have been profiled and their strategies thoroughly analyzed to predict the competitive market outlook.

Blood and Organ Bank Market Report Highlights

Aspects Details
By Product
  • Red Blood Cell Collection, Processing, and Distribution Services
  • Blood Plasma Collection, Processing, and Distribution Services
  • Organ Bank Services
  • Tissue Bank Services
  • Health Screening Services
  • All Other Human Blood Services
  • Reproductive and Stem Cell Bank Services
By Activity
  • Collecting Blood
  • Storing Blood
  • Distributing Blood
  • Storing Organs
  • Distributing Organs
  • Researching Storage Technologies
  • Reproducing Tissues
By End-User
  • Hospitals
  • Diagnostic Centers
  • Blood Banks
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players China Cord Blood Corporation, 21st Century Medicine, New York Blood Centre, Cord Blood Registry, American Red Cross, Musculoskeletal Transplant Foundation, Inc., New York Cord Blood Program, New England Organ Bank, National Organ & Tissue Transplant Organisation, The Living Bank
 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: BLOOD AND ORGAN BANK MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Red Blood Cell Collection, Processing, And Distribution Services

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Blood Plasma Collection, Processing, And Distribution Services

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Organ Bank Services

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Tissue Bank Services

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Health Screening Services

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. All Other Human Blood Services

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

    • 4.8. Reproductive And Stem Cell Bank Services

      • 4.8.1. Key Market Trends, Growth Factors and Opportunities

      • 4.8.2. Market Size and Forecast, By Region

      • 4.8.3. Market Share Analysis, By Country

  • CHAPTER 5: BLOOD AND ORGAN BANK MARKET, BY ACTIVITY

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Activity

    • 5.2. Collecting Blood

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Storing Blood

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Distributing Blood

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Storing Organs

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Distributing Organs

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Researching Storage Technologies

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

    • 5.8. Reproducing Tissues

      • 5.8.1. Key Market Trends, Growth Factors and Opportunities

      • 5.8.2. Market Size and Forecast, By Region

      • 5.8.3. Market Share Analysis, By Country

  • CHAPTER 6: BLOOD AND ORGAN BANK MARKET, BY END-USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End-user

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Diagnostic Centers

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Blood Banks

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Others

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: BLOOD AND ORGAN BANK MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Activity

      • 7.2.4. Market Size and Forecast, By End-user

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Blood And Organ Bank Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Activity
        • 7.2.6.3. Market Size and Forecast, By End-user
      • 7.2.7. Canada Blood And Organ Bank Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Activity
        • 7.2.7.3. Market Size and Forecast, By End-user
      • 7.2.8. Mexico Blood And Organ Bank Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Activity
        • 7.2.8.3. Market Size and Forecast, By End-user
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Activity

      • 7.3.4. Market Size and Forecast, By End-user

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Blood And Organ Bank Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Activity
        • 7.3.6.3. Market Size and Forecast, By End-user
      • 7.3.7. Germany Blood And Organ Bank Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Activity
        • 7.3.7.3. Market Size and Forecast, By End-user
      • 7.3.8. Italy Blood And Organ Bank Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Activity
        • 7.3.8.3. Market Size and Forecast, By End-user
      • 7.3.9. Spain Blood And Organ Bank Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Activity
        • 7.3.9.3. Market Size and Forecast, By End-user
      • 7.3.10. UK Blood And Organ Bank Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Activity
        • 7.3.10.3. Market Size and Forecast, By End-user
      • 7.3.11. Russia Blood And Organ Bank Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Activity
        • 7.3.11.3. Market Size and Forecast, By End-user
      • 7.3.12. Rest Of Europe Blood And Organ Bank Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Activity
        • 7.3.12.3. Market Size and Forecast, By End-user
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Activity

      • 7.4.4. Market Size and Forecast, By End-user

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Blood And Organ Bank Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Activity
        • 7.4.6.3. Market Size and Forecast, By End-user
      • 7.4.7. Japan Blood And Organ Bank Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Activity
        • 7.4.7.3. Market Size and Forecast, By End-user
      • 7.4.8. India Blood And Organ Bank Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Activity
        • 7.4.8.3. Market Size and Forecast, By End-user
      • 7.4.9. South Korea Blood And Organ Bank Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Activity
        • 7.4.9.3. Market Size and Forecast, By End-user
      • 7.4.10. Australia Blood And Organ Bank Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Activity
        • 7.4.10.3. Market Size and Forecast, By End-user
      • 7.4.11. Thailand Blood And Organ Bank Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Activity
        • 7.4.11.3. Market Size and Forecast, By End-user
      • 7.4.12. Malaysia Blood And Organ Bank Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Activity
        • 7.4.12.3. Market Size and Forecast, By End-user
      • 7.4.13. Indonesia Blood And Organ Bank Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Activity
        • 7.4.13.3. Market Size and Forecast, By End-user
      • 7.4.14. Rest of Asia Pacific Blood And Organ Bank Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Activity
        • 7.4.14.3. Market Size and Forecast, By End-user
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Activity

      • 7.5.4. Market Size and Forecast, By End-user

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Blood And Organ Bank Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Activity
        • 7.5.6.3. Market Size and Forecast, By End-user
      • 7.5.7. South Africa Blood And Organ Bank Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Activity
        • 7.5.7.3. Market Size and Forecast, By End-user
      • 7.5.8. Saudi Arabia Blood And Organ Bank Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Activity
        • 7.5.8.3. Market Size and Forecast, By End-user
      • 7.5.9. UAE Blood And Organ Bank Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Activity
        • 7.5.9.3. Market Size and Forecast, By End-user
      • 7.5.10. Argentina Blood And Organ Bank Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Activity
        • 7.5.10.3. Market Size and Forecast, By End-user
      • 7.5.11. Rest of LAMEA Blood And Organ Bank Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Activity
        • 7.5.11.3. Market Size and Forecast, By End-user
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. American Red Cross

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. New England Organ Bank

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. 21st Century Medicine

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. New York Blood Centre

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. The Living Bank

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Musculoskeletal Transplant Foundation, Inc.

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. National Organ And Tissue Transplant Organisation

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. China Cord Blood Corporation

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. New York Cord Blood Program

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Cord Blood Registry

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD AND ORGAN BANK MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL BLOOD AND ORGAN BANK MARKET FOR RED BLOOD CELL COLLECTION, PROCESSING, AND DISTRIBUTION SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL BLOOD AND ORGAN BANK MARKET FOR BLOOD PLASMA COLLECTION, PROCESSING, AND DISTRIBUTION SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL BLOOD AND ORGAN BANK MARKET FOR ORGAN BANK SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL BLOOD AND ORGAN BANK MARKET FOR TISSUE BANK SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL BLOOD AND ORGAN BANK MARKET FOR HEALTH SCREENING SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL BLOOD AND ORGAN BANK MARKET FOR ALL OTHER HUMAN BLOOD SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL BLOOD AND ORGAN BANK MARKET FOR REPRODUCTIVE AND STEM CELL BANK SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL BLOOD AND ORGAN BANK MARKET, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL BLOOD AND ORGAN BANK MARKET FOR COLLECTING BLOOD, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL BLOOD AND ORGAN BANK MARKET FOR STORING BLOOD, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL BLOOD AND ORGAN BANK MARKET FOR DISTRIBUTING BLOOD, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL BLOOD AND ORGAN BANK MARKET FOR STORING ORGANS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL BLOOD AND ORGAN BANK MARKET FOR DISTRIBUTING ORGANS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL BLOOD AND ORGAN BANK MARKET FOR RESEARCHING STORAGE TECHNOLOGIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL BLOOD AND ORGAN BANK MARKET FOR REPRODUCING TISSUES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL BLOOD AND ORGAN BANK MARKET, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL BLOOD AND ORGAN BANK MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL BLOOD AND ORGAN BANK MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL BLOOD AND ORGAN BANK MARKET FOR BLOOD BANKS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. GLOBAL BLOOD AND ORGAN BANK MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. GLOBAL BLOOD AND ORGAN BANK MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA BLOOD AND ORGAN BANK, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 27. U.S. BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 28. U.S. BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 29. U.S. BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 30. CANADA BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. CANADA BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 32. CANADA BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 33. MEXICO BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE BLOOD AND ORGAN BANK, BY REGION, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 40. FRANCE BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 41. FRANCE BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 42. FRANCE BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 43. GERMANY BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. GERMANY BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 45. GERMANY BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 46. ITALY BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 47. ITALY BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 48. ITALY BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 49. SPAIN BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 50. SPAIN BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 51. SPAIN BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 52. UK BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 53. UK BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 54. UK BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 55. RUSSIA BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. RUSSIA BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 57. RUSSIA BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 58. REST OF EUROPE BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 59. REST OF EUROPE BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 60. REST OF EUROPE BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 61. ASIA-PACIFIC BLOOD AND ORGAN BANK, BY REGION, 2022-2032 ($MILLION)
  • TABLE 62. ASIA-PACIFIC BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 63. ASIA-PACIFIC BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 64. ASIA-PACIFIC BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 65. CHINA BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 66. CHINA BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 67. CHINA BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 68. JAPAN BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 69. JAPAN BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 70. JAPAN BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 71. INDIA BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 72. INDIA BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 73. INDIA BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 74. SOUTH KOREA BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 75. SOUTH KOREA BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 76. SOUTH KOREA BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 77. AUSTRALIA BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 78. AUSTRALIA BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 79. AUSTRALIA BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 80. THAILAND BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 81. THAILAND BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 82. THAILAND BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 83. MALAYSIA BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 84. MALAYSIA BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 85. MALAYSIA BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 86. INDONESIA BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 87. INDONESIA BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 88. INDONESIA BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 89. REST OF ASIA PACIFIC BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 90. REST OF ASIA PACIFIC BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 91. REST OF ASIA PACIFIC BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 92. LAMEA BLOOD AND ORGAN BANK, BY REGION, 2022-2032 ($MILLION)
  • TABLE 93. LAMEA BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 94. LAMEA BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 95. LAMEA BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 96. BRAZIL BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 97. BRAZIL BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 98. BRAZIL BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 99. SOUTH AFRICA BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 100. SOUTH AFRICA BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 101. SOUTH AFRICA BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 102. SAUDI ARABIA BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 103. SAUDI ARABIA BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 104. SAUDI ARABIA BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 105. UAE BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 106. UAE BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 107. UAE BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 108. ARGENTINA BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 109. ARGENTINA BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 110. ARGENTINA BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 111. REST OF LAMEA BLOOD AND ORGAN BANK, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 112. REST OF LAMEA BLOOD AND ORGAN BANK, BY ACTIVITY, 2022-2032 ($MILLION)
  • TABLE 113. REST OF LAMEA BLOOD AND ORGAN BANK, BY END-USER, 2022-2032 ($MILLION)
  • TABLE 114. AMERICAN RED CROSS: KEY EXECUTIVES
  • TABLE 115. AMERICAN RED CROSS: COMPANY SNAPSHOT
  • TABLE 116. AMERICAN RED CROSS: OPERATING SEGMENTS
  • TABLE 117. AMERICAN RED CROSS: PRODUCT PORTFOLIO
  • TABLE 118. AMERICAN RED CROSS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. NEW ENGLAND ORGAN BANK: KEY EXECUTIVES
  • TABLE 120. NEW ENGLAND ORGAN BANK: COMPANY SNAPSHOT
  • TABLE 121. NEW ENGLAND ORGAN BANK: OPERATING SEGMENTS
  • TABLE 122. NEW ENGLAND ORGAN BANK: PRODUCT PORTFOLIO
  • TABLE 123. NEW ENGLAND ORGAN BANK: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. 21ST CENTURY MEDICINE: KEY EXECUTIVES
  • TABLE 125. 21ST CENTURY MEDICINE: COMPANY SNAPSHOT
  • TABLE 126. 21ST CENTURY MEDICINE: OPERATING SEGMENTS
  • TABLE 127. 21ST CENTURY MEDICINE: PRODUCT PORTFOLIO
  • TABLE 128. 21ST CENTURY MEDICINE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129. NEW YORK BLOOD CENTRE: KEY EXECUTIVES
  • TABLE 130. NEW YORK BLOOD CENTRE: COMPANY SNAPSHOT
  • TABLE 131. NEW YORK BLOOD CENTRE: OPERATING SEGMENTS
  • TABLE 132. NEW YORK BLOOD CENTRE: PRODUCT PORTFOLIO
  • TABLE 133. NEW YORK BLOOD CENTRE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134. THE LIVING BANK: KEY EXECUTIVES
  • TABLE 135. THE LIVING BANK: COMPANY SNAPSHOT
  • TABLE 136. THE LIVING BANK: OPERATING SEGMENTS
  • TABLE 137. THE LIVING BANK: PRODUCT PORTFOLIO
  • TABLE 138. THE LIVING BANK: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139. MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC.: KEY EXECUTIVES
  • TABLE 140. MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC.: COMPANY SNAPSHOT
  • TABLE 141. MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC.: OPERATING SEGMENTS
  • TABLE 142. MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC.: PRODUCT PORTFOLIO
  • TABLE 143. MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. NATIONAL ORGAN AND TISSUE TRANSPLANT ORGANISATION: KEY EXECUTIVES
  • TABLE 145. NATIONAL ORGAN AND TISSUE TRANSPLANT ORGANISATION: COMPANY SNAPSHOT
  • TABLE 146. NATIONAL ORGAN AND TISSUE TRANSPLANT ORGANISATION: OPERATING SEGMENTS
  • TABLE 147. NATIONAL ORGAN AND TISSUE TRANSPLANT ORGANISATION: PRODUCT PORTFOLIO
  • TABLE 148. NATIONAL ORGAN AND TISSUE TRANSPLANT ORGANISATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. CHINA CORD BLOOD CORPORATION: KEY EXECUTIVES
  • TABLE 150. CHINA CORD BLOOD CORPORATION: COMPANY SNAPSHOT
  • TABLE 151. CHINA CORD BLOOD CORPORATION: OPERATING SEGMENTS
  • TABLE 152. CHINA CORD BLOOD CORPORATION: PRODUCT PORTFOLIO
  • TABLE 153. CHINA CORD BLOOD CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154. NEW YORK CORD BLOOD PROGRAM: KEY EXECUTIVES
  • TABLE 155. NEW YORK CORD BLOOD PROGRAM: COMPANY SNAPSHOT
  • TABLE 156. NEW YORK CORD BLOOD PROGRAM: OPERATING SEGMENTS
  • TABLE 157. NEW YORK CORD BLOOD PROGRAM: PRODUCT PORTFOLIO
  • TABLE 158. NEW YORK CORD BLOOD PROGRAM: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 159. CORD BLOOD REGISTRY: KEY EXECUTIVES
  • TABLE 160. CORD BLOOD REGISTRY: COMPANY SNAPSHOT
  • TABLE 161. CORD BLOOD REGISTRY: OPERATING SEGMENTS
  • TABLE 162. CORD BLOOD REGISTRY: PRODUCT PORTFOLIO
  • TABLE 163. CORD BLOOD REGISTRY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD AND ORGAN BANK MARKET SEGMENTATION
  • FIGURE 2. GLOBAL BLOOD AND ORGAN BANK MARKET
  • FIGURE 3. SEGMENTATION BLOOD AND ORGAN BANK MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN BLOOD AND ORGAN BANK MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALBLOOD AND ORGAN BANK MARKET
  • FIGURE 11. BLOOD AND ORGAN BANK MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. BLOOD AND ORGAN BANK MARKET FOR RED BLOOD CELL COLLECTION, PROCESSING, AND DISTRIBUTION SERVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. BLOOD AND ORGAN BANK MARKET FOR BLOOD PLASMA COLLECTION, PROCESSING, AND DISTRIBUTION SERVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. BLOOD AND ORGAN BANK MARKET FOR ORGAN BANK SERVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. BLOOD AND ORGAN BANK MARKET FOR TISSUE BANK SERVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. BLOOD AND ORGAN BANK MARKET FOR HEALTH SCREENING SERVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. BLOOD AND ORGAN BANK MARKET FOR ALL OTHER HUMAN BLOOD SERVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. BLOOD AND ORGAN BANK MARKET FOR REPRODUCTIVE AND STEM CELL BANK SERVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. BLOOD AND ORGAN BANK MARKET SEGMENTATION, BY BY ACTIVITY
  • FIGURE 20. BLOOD AND ORGAN BANK MARKET FOR COLLECTING BLOOD, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. BLOOD AND ORGAN BANK MARKET FOR STORING BLOOD, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. BLOOD AND ORGAN BANK MARKET FOR DISTRIBUTING BLOOD, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. BLOOD AND ORGAN BANK MARKET FOR STORING ORGANS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. BLOOD AND ORGAN BANK MARKET FOR DISTRIBUTING ORGANS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. BLOOD AND ORGAN BANK MARKET FOR RESEARCHING STORAGE TECHNOLOGIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. BLOOD AND ORGAN BANK MARKET FOR REPRODUCING TISSUES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. BLOOD AND ORGAN BANK MARKET SEGMENTATION, BY BY END-USER
  • FIGURE 28. BLOOD AND ORGAN BANK MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. BLOOD AND ORGAN BANK MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. BLOOD AND ORGAN BANK MARKET FOR BLOOD BANKS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 31. BLOOD AND ORGAN BANK MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 32. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 33. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 34. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 35. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 36. COMPETITIVE DASHBOARD
  • FIGURE 37. COMPETITIVE HEATMAP: BLOOD AND ORGAN BANK MARKET
  • FIGURE 38. Top player positioning, 2022
  • FIGURE 39. AMERICAN RED CROSS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. AMERICAN RED CROSS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. AMERICAN RED CROSS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. NEW ENGLAND ORGAN BANK: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. NEW ENGLAND ORGAN BANK: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. NEW ENGLAND ORGAN BANK: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. 21ST CENTURY MEDICINE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. 21ST CENTURY MEDICINE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. 21ST CENTURY MEDICINE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. NEW YORK BLOOD CENTRE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. NEW YORK BLOOD CENTRE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. NEW YORK BLOOD CENTRE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. THE LIVING BANK: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. THE LIVING BANK: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. THE LIVING BANK: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. NATIONAL ORGAN AND TISSUE TRANSPLANT ORGANISATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. NATIONAL ORGAN AND TISSUE TRANSPLANT ORGANISATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. NATIONAL ORGAN AND TISSUE TRANSPLANT ORGANISATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. CHINA CORD BLOOD CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. CHINA CORD BLOOD CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. CHINA CORD BLOOD CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 63. NEW YORK CORD BLOOD PROGRAM: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 64. NEW YORK CORD BLOOD PROGRAM: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 65. NEW YORK CORD BLOOD PROGRAM: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 66. CORD BLOOD REGISTRY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 67. CORD BLOOD REGISTRY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 68. CORD BLOOD REGISTRY: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Blood And Organ Bank Market

Start reading.
This Report and over 67,068+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers